Loading...
IDenta Corp.
IDTA•PNK
Healthcare
Medical - Diagnostics & Research
$0.49
$0.00(0.00%)

Over the past four quarters, IDenta Corp. demonstrated steady revenue growth, increasing from $459810.00 in Q4 2023 to $366870.00 in Q3 2024. Operating income reached $0.00 in Q3 2024, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $100403.00, reflecting operational efficiency. Net income rose to $102344.00, with EPS at $0.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan